184
Participants
Start Date
June 12, 2020
Primary Completion Date
December 22, 2023
Study Completion Date
November 18, 2024
FT218
once nightly sodium oxybate extended release
Montefiore Sleep-Wake Disorders Center, The Bronx
Geisinger Medical Center, Danville
Brian Abaluck Sleep Medicine, Malvern
Helene A. Emsellem, MD PC, Chevy Chase
TPMG Clinical Research Williamsburg, Williamsburg
Advanced Respiratory and Sleep Medicine, Huntersville
Bogan Sleep Consultants, LLC, Columbia
SleepCare Research Institute, Inc. d/b/a Clinical Research Institute, Stockbridge
NeuroTrials Research Inc, Atlanta
FL Pediatric Research Institute, Winter Park
Sleep Medicine Specialists of South Florida, Miami
Pulmonary Disease Specialists, PA, Kissimmee
Sleep Disorders Center of Alabama, Birmingham
Ohio Sleep Medicine Institute, Dublin
University Hospitals Cleveland Medical Center, Cleveland
Sleep Management Institute Intrepid Research, Cincinnati
Fort Wayne Neurological, Fort Wayne
St. Luke's Hospital - Sleep Medicine and Research Center, Chesterfield
Northwest Houston Neurology, Tomball
Comprehensive Sleep Medicine Associates, Sugar Land
FutureSearch Trials of Neurology, Austin
Alpine Clinical Research Center, Boulder
Delta Waves, Inc., Colorado Springs
SDS Clinical Trials, Santa Ana
Stanford Sleep Medicine, Redwood City
Baystate Medical Center, Springfield
Sleep Therapy & Research Center, San Antonio
West Perry Sound Health Center, Parry Sound
Jodha Tishon Inc., Toronto
Lead Sponsor
Avadel
INDUSTRY